Literature DB >> 33922381

The Impact and Burden of Neurological Sequelae Following Bacterial Meningitis: A Narrative Review.

Nicoline Schiess1, Nora E Groce2, Tarun Dua1.   

Abstract

The burden, impact, and social and economic costs of neurological sequelae following meningitis can be devastating to patients, families and communities. An acute inflammation of the brain and spinal cord, meningitis results in high mortality rates, with over 2.5 million new cases of bacterial meningitis and over 236,000 deaths worldwide in 2019 alone. Up to 30% of survivors have some type of neurological or neuro-behavioural sequelae. These include seizures, hearing and vision loss, cognitive impairment, neuromotor disability and memory or behaviour changes. Few studies have documented the long-term (greater than five years) consequences or have parsed out whether the age at time of meningitis contributes to poor outcome. Knowledge of the socioeconomic impact and demand for medical follow-up services among these patients and their caregivers is also lacking, especially in low- and middle-income countries (LMICs). Within resource-limited settings, the costs incurred by patients and their families can be very high. This review summarises the available evidence to better understand the impact and burden of the neurological sequelae and disabling consequences of bacterial meningitis, with particular focus on identifying existing gaps in LMICs.

Entities:  

Keywords:  WHO meningitis roadmap; burden; disability; meningitis; neurological sequelae; social and economic costs; tuberculous meningitis

Year:  2021        PMID: 33922381     DOI: 10.3390/microorganisms9050900

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  53 in total

1.  Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset.

Authors:  Vicki Anderson; Peter Anderson; Keith Grimwood; Terry Nolan
Journal:  J Pediatr Psychol       Date:  2004-03

2.  Survival and sequelae of meningococcal meningitis in Ghana.

Authors:  A Hodgson; T Smith; S Gagneux; I Akumah; M Adjuik; G Pluschke; F Binka; B Genton
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

3.  Manson Lecture. Meningococcal meningitis in Africa.

Authors:  B Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jul-Aug       Impact factor: 2.184

4.  Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan.

Authors:  Satoshi Iwata; Misako Takata; Miyuki Morozumi; Isao Miyairi; Keita Matsubara; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2020-12-07       Impact factor: 2.211

5.  Clinical features and prognostic factors in adults with bacterial meningitis.

Authors:  Diederik van de Beek; Jan de Gans; Lodewijk Spanjaard; Martijn Weisfelt; Johannes B Reitsma; Marinus Vermeulen
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

6.  Cognitive impairment in adults with good recovery after bacterial meningitis.

Authors:  Diederik van de Beek; Ben Schmand; Jan de Gans; Martijn Weisfelt; Heleen Vaessen; Jacob Dankert; Marinus Vermeulen
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

7.  Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis.

Authors:  T Kilpi; M Anttila; M J Kallio; H Peltola
Journal:  Pediatr Infect Dis J       Date:  1993-03       Impact factor: 2.129

8.  [Prognosis of purulent meningitis in the infant and young child].

Authors:  A Mhirsi; R Boussoffara; A Ayadi; H Soua; N Driss; Y Belkhir; H Dalel; H Braham; H Pousse; K Essghairi
Journal:  Tunis Med       Date:  1992-02

9.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Authors: 
Journal:  Lancet       Date:  2020-10-17       Impact factor: 202.731

10.  Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.

Authors:  Heidi M Soeters; Alpha Oumar Diallo; Brice W Bicaba; Goumbi Kadadé; Assétou Y Dembélé; Mahamat A Acyl; Christelle Nikiema; Adodo Yao Sadji; Alain N Poy; Clement Lingani; Haoua Tall; Souleymane Sakandé; Félix Tarbangdo; Flavien Aké; Sarah A Mbaeyi; Jennifer Moïsi; Marietou F Paye; Yibayiri Osee Sanogo; Jeni T Vuong; Xin Wang; Olivier Ronveaux; Ryan T Novak
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

View more
  4 in total

1.  Editorial for the Special Issue: Bacterial Meningitis-Epidemiology and Vaccination.

Authors:  James M Stuart
Journal:  Microorganisms       Date:  2021-04-24

2.  Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B in a nursery school, Wallonia, Belgium, 2018.

Authors:  Stéphanie Jacquinet; Wesley Mattheus; Sophie Quoilin; Chloé Wyndham-Thomas; Charlotte Martin; Dimitri Van der Linden; André Mulder; Julie Frère; Carole Schirvel
Journal:  Euro Surveill       Date:  2022-03

3.  Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan.

Authors:  Bin Chang; Kosuke Tamura; Hiroyuki Fujikura; Hiroshi Watanabe; Yoshinari Tanabe; Koji Kuronuma; Jiro Fujita; Kengo Oshima; Takaya Maruyama; Shuichi Abe; Kei Kasahara; Junichiro Nishi; Tetsuya Kubota; Yuki Kinjo; Yusuke Serizawa; Reiko Shimbashi; Munehisa Fukusumi; Tomoe Shimada; Tomimasa Sunagawa; Motoi Suzuki; Kazunori Oishi
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

4.  Defeating meningitis by 2030 - an ambitious target.

Authors:  Brian Greenwood; Samba Sow; Marie-Pierre Preziosi
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-10-01       Impact factor: 2.184

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.